Target intelligence / Profile preview

Carbohydrate-binding modules recognizing β-glucan (CBM)

Target
CBM
Molecular classification
Protein domain, Carbohydrate-binding module, Non-catalytic module
01

Overview

Carbohydrate-binding modules (CBMs) that recognize β-glucan are non-catalytic protein domains typically found within multi-modular carbohydrate-active enzymes (CAZymes), such as glucanases and cellulases. These modules function by specifically binding to various β-glucan structures, including β-1,3-glucans (e.g., laminarin, curdlan), β-1,4-glucans (e.g., cellulose), and mixed-linkage β-1,3-1,4-glucans. Their primary biological role is to tether the parent enzyme to its polysaccharide substrate, increasing the local concentration of the enzyme and thereby enhancing the efficiency of the catalytic domain through a proximity effect. While CBMs are predominantly found in bacteria, fungi, and plants, they are of significant interest in biotechnology for biomass conversion and as molecular probes for detecting specific glycans in complex biological samples. In a medical context, they are not traditional human therapeutic targets but are explored as tools for targeted drug delivery to fungal cell walls or as components of diagnostic assays for fungal infections. They should be distinguished from human β-glucan receptors like Dectin-1, which initiate immune signaling upon binding.

Other names
Beta-glucan binding modulesGlucan-binding domainsCBM families (4, 6, 11, 13, 32, 39, 43, 44, 46, 52, 54, 56, 65, 72, 76, 79, 80, 81, 85)Carbohydrate-binding module
02

Mechanism of action

Substrate binding and enzyme targeting

03

Biological functions

Substrate targetingProximity effectPolysaccharide recognitionCell wall attachmentEnhancement of enzymatic hydrolysis
04

Disease associations

InfectionFungal pathogenesisBacterial pathogenesis
05

Safety considerations

Immunogenicity of non-human protein domains

Beyond the preview

Go deeper on Carbohydrate-binding modules recognizing β-glucan (CBM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbohydrate-binding modules recognizing β-glucan (CBM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call